AMAG PHARMACEUTICALS, INC. 3 SEC Filings

Filed On	Filing
19 Jun 2020	Form 3: Piekos Brian, Interim CFO Holds 31,538 shares of Common Stock
30 Apr 2020	Form 3: Myers Scott Dunseth, Director No securities owned
03 Jan 2020	Form 3: Schick Kelly, Chief Human Resources Officer Holds 17,150 shares of Common Stock
10 Oct 2019	Form 3: Fonteyne Paul R., Director Holds 0 shares of No securities beneficially owned
16 Sep 2019	Form 3: Shea Kenneth, 10% owner Holds 5,000 shares of Common Stock, par value $0.01 per share
15 Aug 2019	Form 3: Caligan Partners Lp, 10% owner and 2 others Holds 3,499,428 shares of Common Stock, par value $0.01 per share
29 Jul 2019	Form 3: Camber Capital Management Lp, 10% owner Holds 4,005,000 shares of Common Stock
27 Jun 2019	Form 3: Armistice CAPITAL, Llc, 10% owner and 2 others Holds 3,376,984 shares of Common Stock, par value $0.01 per share
12 Apr 2019	Form 3: Phillips Anne M., Director Holds 0 shares of No securities beneficially owned
12 Apr 2019	Form 3: O'Brien Kathrine, Director Holds 0 shares of No securities are beneficially owned
05 Apr 2019	Form 3: Casciano Anthony, Chief Commercial Officer Holds 45,852 shares of Common Stock
02 May 2018	Form 3: Butcher James Alan, EVP, Chief Business Officer Holds 0 shares of No securities are beneficially owned.
05 Dec 2017	Form 3: Bolgiano Elizabeth Scott, Chief Human Resources Officer Holds 42,155 shares of Common Stock
22 Dec 2016	Form 3: Kelley Brian P, Director Holds 0 shares of No securities are beneficially owned
11 Apr 2016	Form 3: Myles Edward H, Chief Financial Officer Holds 0 shares of No securities beneficially owned
05 Jan 2016	Form 3: Grund Nicholas, Chief Commercial Officer Holds 0 shares of No securities beneficially owned.
02 Sep 2015	Form 3: Crouse Geoffrey, EVP Holds 0 shares of No securities are beneficially owned.
25 Aug 2015	Form 3: Vittiglio Joseph, SVP, General Counsel Holds 0 shares of No securities are beneficially owned.
03 Jun 2015	Form 3: Krop Julie, SVP Clinical & Regulatory, CMO Holds 0 shares of No securities are benefically owned.
24 Nov 2014	Form 3: Wilson Kenneth H, SVP, Sales and Marketing Holds 5,388 shares of Common Stock

Comments